A method of treating wounds by enhancing expression of procollagen
US6670351B1
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
WO9945020A1
Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
ZA9901669B
Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs.
WO9917821A1
Device for administration of viscoelastic substance
IL131655D0
Isolation of tissue specific ligands and their use for targeting pharmaceuticals to organs
US6576659B1
Use of oxandrolone in the treatment of burns an other wounds
US5872147A
Use of oxandrolone in the treatment of chronic obstructive pulmonary disease
WO9824451A1
Uses of oxandrolone
US6001604A
Refolding of proinsulins without addition of reducing agents
IL120245D0
Enzymatically active analogs and mutants of human manganese superoxide dismutase
IL116754D0
Method for relieving or treating skin discomfort
IL116696D0
Production of enzymatically active recombinant carboxypeptidase b
US5863534A
Polypeptide having factor Xa inhibitory method of reducing blood coagulation with a novel polypeptide having factor Xa inhibitory activity
US6008193A
Methods of using human von Willebrand factor GPIb binding domain polypeptides
US5670371A
Bacterial expression of superoxide dismutase
US6030611A
Therapeutic SOD compositions and uses thereof
US5759816A
Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods
US5763215A
Method of removing N-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby
